HeraMED CEO and Cofounder Mr. David Groberman said: “This is a truly significant milestone for HeraMED. I am delighted we have reached this agreement with JHC as it demonstrates that our strategy of delivering clinical validation of the HeraCARE platform, which led to a successful paid pilot, provided the correct foundation for broader commercial rollout of HeraCARE within the hospital. 2022 will be a transformative year for HeraMED as we work towards delivering similar deployments with other key partners.
About the Commercial Agreement with JHC The key terms of the agreement are as follows:
● The commercial agreement is a 12-month extension of the commercial terms agreed under the paid pilot.
● HMD and JHC will continue discussions to extend this agreement for an additional three years
● HeraMED will gradually supply JHC with licences and equipment at a pace of approximately 400 licences each quarter to support JHC’s requirements to offer the new connected maternity care model to their audience of pregnancies
● Total estimated HeraCARE licenses fee for year number one based on the accumulated licenses as described is approximately A$ 220,000
- Forums
- ASX - By Stock
- HMD
- Ann: JHC agrees to full commercial rollout of HeraCARE
Ann: JHC agrees to full commercial rollout of HeraCARE, page-4
-
-
- There are more pages in this discussion • 107 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $13.93M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $11.15K | 530K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 743583 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 200000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 743583 | 0.021 |
1 | 348995 | 0.020 |
2 | 1042548 | 0.015 |
1 | 200000 | 0.014 |
1 | 500000 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 200000 | 1 |
0.027 | 400000 | 2 |
0.028 | 150000 | 1 |
0.029 | 500000 | 1 |
0.050 | 102000 | 1 |
Last trade - 11.35am 10/10/2024 (20 minute delay) ? |
Featured News
HMD (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online